Suppr超能文献

合成代谢类固醇诱导的肝毒性:是否被夸大了?

Anabolic steroid-induced hepatotoxicity: is it overstated?

作者信息

Dickerman R D, Pertusi R M, Zachariah N Y, Dufour D R, McConathy W J

机构信息

The Department of Biomedical Science, University of North Texas Health Science Center, Fort Worth 76107-2699, USA.

出版信息

Clin J Sport Med. 1999 Jan;9(1):34-9. doi: 10.1097/00042752-199901000-00007.

Abstract

OBJECTIVE

There have been numerous reports of hepatic dysfunction secondary to anabolic steroid use based on elevated levels of serum aminotransferases. This study was conducted to distinguish between serum aminotransaminase elevations secondary to intense resistance training and anabolic steroid-induced hepatotoxicity in elite bodybuilders.

DESIGN

This was a case-control study of serum chemistry profiles from bodybuilders using and not using anabolic steroids with comparisons to a cohort of medical students and patients with hepatitis.

PARTICIPANTS

The participants were bodybuilders taking self-directed regimens of anabolic steroids (n = 15) and bodybuilders not taking steroids (n = 10). Blood chemistry profiles from patients with viral hepatitis (n = 49) and exercising and nonexercising medical students (592) were used as controls.

MAIN OUTCOME MEASURES

The focus in blood chemistry profiles was aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltranspeptidase (GGT), and creatine kinase (CK) levels.

RESULTS

In both groups of bodybuilders, CK, AST, and ALT were elevated, whereas GGT remained in the normal range. In contrast, patients with hepatitis had elevations of all three enzymes: ALT, AST, and GGT. Creatine kinase (CK) was elevated in all exercising groups. Patients with hepatitis were the only group in which a correlation was found between aminotransferases and GGT.

CONCLUSION

Prior reports of anabolic steroid-induced hepatotoxicity based on elevated aminotransferase levels may have been overstated, because no exercising subjects, including steroid users, demonstrated hepatic dysfunction based on GGT levels. Such reports may have misled the medical community to emphasize steroid-induced hepatotoxicity when interpreting elevated aminotransferase levels and disregard muscle damage. For these reasons, when evaluating hepatic function in cases of anabolic steroid therapy or abuse, CK and GGT levels should be considered in addition to ALT and AST levels as essential elements of the assessment.

摘要

目的

基于血清氨基转移酶水平升高,已有大量关于使用合成代谢类固醇继发肝功能障碍的报道。本研究旨在区分精英健美运动员中因高强度抗阻训练继发的血清氨基转移酶升高与合成代谢类固醇诱导的肝毒性。

设计

这是一项病例对照研究,对使用和未使用合成代谢类固醇的健美运动员的血清化学指标进行分析,并与一组医学生和肝炎患者进行比较。

参与者

参与者包括自行使用合成代谢类固醇的健美运动员(n = 15)和未使用类固醇的健美运动员(n = 10)。病毒性肝炎患者(n = 49)以及运动和不运动的医学生(592名)的血液化学指标用作对照。

主要观察指标

血液化学指标重点关注天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、γ-谷氨酰转肽酶(GGT)和肌酸激酶(CK)水平。

结果

两组健美运动员的CK、AST和ALT均升高,而GGT仍在正常范围内。相比之下,肝炎患者的所有三种酶(ALT、AST和GGT)均升高。所有运动组的肌酸激酶(CK)均升高。肝炎患者是唯一一组在氨基转移酶和GGT之间发现相关性的人群。

结论

先前基于氨基转移酶水平升高而报道的合成代谢类固醇诱导的肝毒性可能被夸大了,因为包括类固醇使用者在内,没有运动受试者基于GGT水平显示肝功能障碍。此类报道可能误导医学界在解释氨基转移酶水平升高时强调类固醇诱导的肝毒性,而忽视肌肉损伤。基于这些原因,在评估合成代谢类固醇治疗或滥用病例中的肝功能时,除了ALT和AST水平外,还应将CK和GGT水平作为评估的基本要素加以考虑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验